Investor Update
Basel, 2 June 2008
Reminder:
Invitation to Roche investor science event - phase IIb data on R1583 GLP-1 analogue and overall
update on Roche´s franchise in diabetes & metabolism
Monday, 9 June 2008
We
kindly invite investors and analysts to participate in an event to present and discuss new phase IIb
data and results on R1583 GLP-1 analogue presented during the 2008 ADA (American Diabetes Association)
Annual Scientific Sessions. Further, Roche will provide an overall update on its franchise in diabetes
and metabolism.
The Roche investor science
event will take place on:
Monday, 9 June 2008 from 6:30 pm to 8:00 pm Pacific Time
Hotel
“W” San Francisco
181 3rd Street
San Francisco, California 94103
Room:
Great Room 2
Following presentations and the Q&A
session, Roche Investor Relations is inviting participants to stay for a light dinner. Additonally,
during the dinner there will be an opportunity to attend a diagnostics experimentarium and explore Roche´s
key products in Diabetes Care (blood glucose meters, insulin delivery systems and disease & information
management solutions).
Please contact Misty Vita at misty.vita@roche.com
immediately if you would like to attend this event or if you have any questions.
Conference
call
Investors and analysts who cannot attend in person in San Francisco are also
invited to join the accompanying conference call either by live audio webcast or by telephone.
Live
audio webcast
The live conference call can be accessed via http://ir.roche.com.
Following the event, an MP3 file will be made available for download.
Phone
conference call
The live conference call can be accessed using the following dial-in
numbers:
+41 91 610 5600 (Switzerland)
+44 207
107 0611 (UK)
+1 866 291 4166 (USA)
Please dial in to
the conference call 10 – 15 minutes before the call is scheduled to start.
A
replay of the conference call will be available one hour after the conference call and then for 48 hours.
The replay can be accessed using the following dial-in numbers:
+41
91 612 4330 (Switzerland)
+44 207 108 6233 (UK)
+1 866 416 2558 (USA)
Enter the ID 17060 followed by the # sign
At
the time of the conference call, the accompanying presentation will be available from the IR website
at http://ir.roche.com.